Abstract: A composition useful in treating Multiple Sclerosis and HTLV-1 myelopathy in humans comprises:i) a peptide having as its active portion, an amino acid sequence of the formula:-Thr-Thr-Asn-Tyr-Thr-; andii) a pharmaceutically acceptable carrier for said peptide.
Type:
Grant
Filed:
November 8, 1995
Date of Patent:
November 11, 1997
Assignee:
Reed MacFadden, Ltd.
Inventors:
Douglas K. MacFadden, Peter L. Carlen, Penelope Reed Doob